Thursday, 6 July 2017

Oxford BioMedica wins big contract for Novartis cell therapy

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million (77.32 million pounds) over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.


from Reuters: Top News http://uk.reuters.com/article/uk-oxford-biomedica-novartis-idUKKBN19R0NQ?feedType=RSS&feedName=topNews

No comments:

Post a Comment